PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Protech ECS

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Protech ECS Released A Portal Based Program for Chemical Hazardous Inventory Classification Summary - Protech ECS announces the development and release of their first portal based program the Chemical Hazardous Inventory Classification System, also known as CHICS - Bio2008.org
Protech ECS Released A Portal Based Program for Chemical Hazardous Inventory Classification Summary

 

NewswireToday - /newswire/ - San Diego, CA, United States, 2008/06/06 - Protech ECS announces the development and release of their first portal based program the Chemical Hazardous Inventory Classification System, also known as CHICS - Bio2008.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Protech ECS is proud to announce the development and release of their first portal based program the Chemical Hazardous Inventory Classification System or CHICS. In early stage trails, moderately sized inventory FBP 500 summary reports were successfully completed within days. Chemical inventories gathered at the facility can now be uploaded into the CHICS database hosted on Protech’s SharePoint portal in real time. The CHICS program is designed to categorize compounds by hazard class and identify unclassified chemicals for evaluation. This capability of direct access and process automation has improved the time to produce the summary reports considerably.

The CHICS program utilizes the Microsoft SQL database and Microsoft SharePoint portal intelligent data processing and storage allowing the database to grow exponentially.

“We immediately recognized the advantages to automate CHICS using the SharePoint Portal”, Barry Rutledge, Managing Partner of Protech Environmental Compliance and Safety, LLC. Dba Protech ECS.

The CHICS service is the first of a series of EHS tools Protech ECS plans to release utilizing Microsoft’s SharePoint portal technology. Protech ECS will be demonstrating the CHICS program at the Bio2008 convention held in San Diego in June; link Bio2008.org

Protech ECS was established in 1999 as an EHS outsourcing service with seasoned Environmental Health and Safety Specialists. This hands-on service is designed to function as an extension of your existing environmental compliance and occupational safety program. Protech ECS specializes in the development, implementation and maintenance of these programs on the operational level.

For more information about the CHICS program and service needs, contact the Protech ECS directly at 888-331-7327. To see a full demonstration of CHICS, visit us at San Diego Convention Center Bio2008 Conference June 17th-20th at booth 2036.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Protech ECS

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Protech ECS Released A Portal Based Program for Chemical Hazardous Inventory Classification Summary

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michelle Bacaycay - ProtechECS.com 
888-331-7327 Mbacaycay[.]protechecs.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Protech ECS securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Protech ECS / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)